Newsletter | November 1, 2024

11.01.24 -- Why Job Rotations Are Critical To Shaping Tomorrow's Leaders

NEW PODCAST EPISODE

Live from ARM's Meeting On The Mesa With Kiji Therapeutics' Dr. Miguel Forte

This episode of Cell & Gene: The Podcast was recorded on site during ARM's 2024 Meeting on the Mesa in Phoenix. Tune in to hear Host Erin Harris talk to Miguel Forte, M.D., Ph.D., CEO of Kiji Therapeutics, President of ISCT, and Executive Committee Member of ARM about Kiji's clinical plan and why iPSC-MSC therapy for inflammatory diseases shows great promise. Listen now and subscribe so you never miss an episode!

FROM THE EDITOR

Why Job Rotations Are Critical To Shaping Tomorrow's Leaders

Job rotations provide an opportunity for promising, high-potential employees to grow and learn new parts of the business. Kristina Fusella describes the challenges and multifactorial benefits of job rotations as a tool for leadership development at Novo Nordisk.

INDUSTRY INSIGHTS

Evolution Of ERP In Biotech And Integration Challenges

Consolidating various software systems enables efficient management of direct fees, pass-throughs, and investigator grants within a single platform, providing a comprehensive view of your trials' financial health.

Mastering The Art Of Developing A Successful Bispecific Antibody

Learn innovative strategies to overcome the complexities of bispecific antibody development, from intelligent design to efficient purification techniques.

Discover Why Electronic Revisions Of ICFs Are Easier

What does the ICF amendment or revision process look like within a digital platform and is this harder or easier than traditional paper-based approaches?

Navigating A Rare Disease Clinical Trial: A Patient And Family Perspective

Becky Vivian shares her inspiring story, offering readers valuable insights into the unique challenges faced by caregivers of rare disease patients.

CONTRIBUTE TO LIFE SCIENCE LEADER

Article Submission Guidelines

Think you have a good idea for an article that Life Science Leader readers would find valuable?  Read these guidelines first before submitting your idea or your article to our editorial director.